ClinConnect ClinConnect Logo
Search / Trial NCT06117761

Combined Activity and Cognitive Intervention for ICU Survivors

Launched by THE UNIVERSITY OF HONG KONG · Oct 31, 2023

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Post Intensive Care Syndrome Pics Intensive Care Unit Icu Survivors Home Based Exercise

ClinConnect Summary

With the growing cohort of patients surviving after ICU treatment, the long-term consequences of critical illness have gained increased attention in the past decade. It is common for ICU survivors to experience long-term impairments in one or more domains of physical, cognitive or psychological functioning that persist beyond acute care hospitalization for a critical illness, impairments that are collectively known as post-intensive care syndrome (PICS).

As PICS is a relatively new syndrome, research is accumulating on different approaches to tackling it. There are several limitations on p...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Chinese adults aged ≥18
  • 2. has been admitted to ICU for at least 4 days
  • 3. discharged home
  • 4. able to perform basic activities of daily living before ICU admission
  • 5. living with family
  • 6. has an electronic device that can access the internet (patient/family)
  • 7. able to walk for at least 10 metres (assisted or unassisted)
  • Exclusion Criteria:
  • 1. cannot read Chinese
  • 2. has musculoskeletal injury precluding exercise training
  • 3. is receiving structured out-patient pulmonary or cardiac rehabilitation after discharge
  • 4. has clinically evident dementia or significant impairment from an acute brain problem (e.g. traumatic brain injury, stroke, subarachnoid haemorrhage or hypoxic brain injury) that precludes following the study protocol
  • 5. has prolonged length of stay (≥28 days) in the step-down wards

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Polly Li, Dr

Principal Investigator

The University of Hong Kong, School of Nursing

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported